BCMA-Directed CAR T Cells in Relapsed Refractory Multiple Myeloma: Highlights From SOHO 2021
Lisa Nodzon PhD, APRN, AOCNP®
J Adv Pract Oncol 2022;13(suppl 1):23–25 |
© 2022 Harborside™
Lisa Nodzon PhD, APRN, AOCNP®, of Moffitt Cancer Center, reviews data on clinical trials and future directions in BCMA-directed CAR T cells presented in a session by Jesus G. Berdeja, MD, of Sarah Cannon Cancer Institute, at the 2021 SOHO Annual Meeting.
For access to the full length article, please sign in